Daily Anesthesiology Research Analysis
Three impactful anesthesiology-related studies span basic science, neuroprognostication, and perioperative outcomes. A mechanistic study uncovers a novel XPO1–HMGB1 pathway driving morphine tolerance with therapeutic potential. Continuous EEG assessed early and late improves outcome prediction after cardiac arrest without false positives, while a 14,129-patient cohort links preoperative sleep disturbance to wide-ranging postoperative adverse outcomes.
Summary
Three impactful anesthesiology-related studies span basic science, neuroprognostication, and perioperative outcomes. A mechanistic study uncovers a novel XPO1–HMGB1 pathway driving morphine tolerance with therapeutic potential. Continuous EEG assessed early and late improves outcome prediction after cardiac arrest without false positives, while a 14,129-patient cohort links preoperative sleep disturbance to wide-ranging postoperative adverse outcomes.
Research Themes
- Mechanisms of opioid tolerance and potential therapeutic targets
- Continuous EEG prognostication after cardiac arrest
- Impact of preoperative sleep disturbance on perioperative outcomes
Selected Articles
1. Parylation dependent nuclear export of HMGB1 via exportin 1 contributes to morphine tolerance.
In a rat model, morphine tolerance was driven by STK38-mediated phosphorylation of XPO1 and PARP1-dependent PARylation of HMGB1, enabling XPO1-dependent nuclear export and extracellular release of HMGB1. Pharmacologic co-inhibition of XPO1 and PARP1 reversed established morphine tolerance and mechanical hypersensitivity, whereas intrathecal HMGB1 negated these benefits.
Impact: This work identifies a previously unrecognized XPO1–HMGB1 axis as a mechanistic driver of opioid tolerance and demonstrates a tractable combinatorial therapy to reverse it. It reframes nuclear export as a therapeutic node in analgesic tolerance.
Clinical Implications: Although preclinical, targeting nuclear export (XPO1) and PARP1 could augment perioperative opioid analgesia, limit dose escalation, and reduce opioid-related adverse effects. Translation will require safety, CNS-penetration, and selectivity assessments.
Key Findings
- Chronic morphine upregulated spinal XPO1 and induced STK38-dependent phosphorylation at Ser1010, enhancing nuclear export function.
- CSF proteomics showed elevated HMGB1 after morphine; XPO1 inhibition suppressed HMGB1 secretion.
- PARP1-mediated PARylation of HMGB1 was required for its interaction with XPO1 and nuclear export.
- Combined low-dose inhibition of XPO1 and PARP1 reversed morphine tolerance and mechanical hypersensitivity; intrathecal HMGB1 abolished these effects.
Methodological Strengths
- Multimodal approach integrating spinal biochemistry, CSF proteomics, protein–protein interaction assays, and behavioral phenotyping.
- Mechanistic causality supported by kinase mapping (STK38), PARP1 modulation, and pharmacologic co-inhibition with behavioral rescue.
Limitations
- Preclinical animal study without human validation; translational relevance and dosing/safety remain unknown.
- Potential off-target effects of XPO1/PARP1 inhibitors and systemic immunomodulation require careful evaluation.
Future Directions: Validate the XPO1–HMGB1 pathway in human tissues/CSF from opioid-tolerant patients; test CNS-selective XPO1/PARP1 modulation in large animals; assess safety, dosing, and potential synergy with multimodal analgesia.
BACKGROUND: Nucleocytoplasmic transport has been implicated in chronic pain, particularly through importin-mediated nuclear import. However, the role of nuclear export in opioid-induced adaptations remains unclear. Exportin 1 (XPO1), a key nuclear export protein, has not been studied in the context of morphine tolerance. This study explores the contribution of XPO1 and its interaction with pro-inflammatory mediators in the development of opioid tolerance and hyperalgesia. METHODS: A rat model of chronic morphine administration was used to assess changes in spinal XPO1 expression and activity. Phosphorylation status of XPO1 and upstream kinases were evaluated by immunoblotting. Proteomic analysis of cerebrospinal fluid (CSF) was performed to identify secreted factors associated with morphine exposure. Co-immunoprecipitation and in vitro assays were used to examine the interaction between XPO1 and high mobility group box 1 (HMGB1). The role of PARP1-mediated poly(ADP-ribosyl)ation (PARylation) in regulating HMGB1 nuclear export was also investigated. Behavioral assays were used to assess the impact of pharmacological inhibition of XPO1 and PARP1 on morphine tolerance and nociceptive hypersensitivity. RESULTS: Chronic morphine exposure led to significant upregulation of XPO1 in spinal neurons, accompanied by phosphorylation at serine 1010 by serine/threonine kinase 38 (STK38), which enhanced its nuclear export function. CSF proteomics revealed elevated levels of HMGB1, a pro-inflammatory mediator. XPO1 inhibition suppressed HMGB1 secretion. Mechanistically, PARP1-mediated PARylation of HMGB1 was essential for its interaction with XPO1 and subsequent nuclear export. Combined low-dose inhibition of XPO1 and PARP1 reversed established morphine tolerance and alleviated mechanical hypersensitivity. However, intrathecal administration of recombinant HMGB1 abolished these effects, reinstating morphine tolerance. CONCLUSIONS: These findings reveal a novel mechanism by which STK38-driven phosphorylation of XPO1 and PARP1-mediated modification of HMGB1 coordinate nuclear export and extracellular signaling in the context of opioid tolerance. Dual inhibition of XPO1 and PARP1 represents a promising therapeutic strategy to suppress neuroinflammation and enhance opioid analgesic efficacy.
2. Assessing both early and late EEG patterns improves prediction of outcome after cardiac arrest.
In comatose post–cardiac arrest patients from the TTM2 cohort, early (≤24 h) and late (>24 h) highly malignant EEG patterns each achieved 100% specificity for poor outcome, but limited sensitivity. Combining early and late predictors and adding cEEG information over 36 h increased sensitivity to 49% without false positives; a continuous background within 12 h predicted good outcome.
Impact: Provides a pragmatic, time-structured cEEG strategy that improves sensitivity while maintaining zero false positives in this cohort, directly informing neuroprognostication bundles.
Clinical Implications: Incorporate continuous EEG during the first 36 h post–cardiac arrest; actively search for early and late highly malignant patterns while recognizing continuous background early as a favorable sign. Use within multimodal prognostication to guide timing of decisions.
Key Findings
- Early EEG predictors (≤24 h) had 100% specificity and up to 30% sensitivity for poor outcome.
- Late EEG predictors (>24 h) had 100% specificity and up to 32% sensitivity.
- Combining early and late cEEG predictors across time improved sensitivity to 49% by 36 h without false positive survivors (p = 0.001).
- A continuous EEG background within 12 h predicted good outcome (sensitivity 61%, specificity 87%).
Methodological Strengths
- Blinded cEEG assessment using standardized ACNS terminology within a contemporary randomized trial cohort (TTM2).
- Predefined early and late EEG categories aligned with European post-resuscitation guidelines.
Limitations
- Observational design with potential self-fulfilling prophecy bias due to withdrawal-of-care influenced by EEG findings.
- Modest sample size (n=191) limits precision of sensitivity estimates and subgroup analyses.
Future Directions: Prospective multicenter validation with standardized treatment-limitation policies; integrate quantitative EEG metrics and multimodal biomarkers to further increase sensitivity without compromising specificity.
OBJECTIVE: Previously proposed "synchronous EEG patterns" predict poor outcome within 24 h after cardiac arrest (CA). We investigate the prognostic performance of these early EEG predictors in addition to the late EEG predictors (>24 h) recommended in the European post-resuscitation guidelines. METHODS: Observational substudy of the TTM2-trial including consecutive comatose resuscitated patients. Continuous EEG-monitoring (cEEG) was blindly assessed using the American Clinical Neurophysiology Societýs standardised EEG terminology and categorised into early EEG predictors (burst-suppression with identical or highly epileptiform bursts, or suppression with generalised periodic discharges) and late EEG predictors (heterogenous burst-suppression or suppression). Poor outcome was defined as modified Rankin Scale 4-6 at six months. RESULTS: Of 191 included patients, 53 % had poor outcome. Early EEG predictors had 100 %[CI 96-100] specificity at all time-points and maximal sensitivity 30 %[CI 21-40] before 24 h. Late EEG predictors had 100 %[CI 96-100] specificity beyond 24 h with maximal sensitivity 32 %[CI 21-43]. Using both early and late EEG predictors, and gradually adding cEEG-information from consecutive time-epochs, sensitivity increased to 49 %[CI 39-59] up to 36 h after CA (p = 0.001). A continuous background within 12 h predicted good outcome (sensitivity 61 %[CI 50-71]; specificity 87 %[CI 79-93]). CONCLUSION: Searching for both early EEG predictors (e.g. identical burst-suppression) and late EEG predictors (e.g. heterogenous burst-suppression > 24 h) significantly improved sensitivity of poor outcome prediction without false positive survivors in this cohort. A self-fulfilling prophecy may have affected our results. cEEG during the first two days after CA identified half of the patients with a long-term poor outcome and half of the patients with a good outcome.
3. Associations of preoperative sleep disturbance with intraoperative and postoperative adverse outcomes among Chinese surgical patients: evidence from the China surgery and anesthesia cohort (CSAC).
In 14,129 surgical patients aged 40–65 years, preoperative sleep disturbance (PSQI) was associated with increased risks of two in-hospital and all eight post-discharge adverse outcomes. The highest risks occurred in patients with multiple sleep problems and daytime dysfunction, and mediation analyses implicated postoperative sleep disturbance and depression as mediators of long-term adverse outcomes.
Impact: Large, contemporary, multicenter evidence links preoperative sleep disturbance to a broad spectrum of adverse outcomes and elucidates mediating pathways, highlighting a modifiable perioperative risk factor.
Clinical Implications: Implement routine preoperative sleep screening (e.g., PSQI), stratify high-risk 'multiple problems/daytime dysfunction' phenotypes, and deploy sleep optimization and mental health interventions pre- and postoperatively to mitigate long-term adverse outcomes.
Key Findings
- Among 14,129 patients (mean age 52.3 years; 58.8% female), preoperative sleep disturbance was associated with two in-hospital and all eight post-discharge adverse outcomes.
- Strongest associations were for postoperative moderate-to-severe sleep disturbance (ORs 3.88–18.64 at 1 month; 3.44–13.31 at 6 months; 3.98–15.58 at 12 months) and depression (ORs 1.88–5.60 across timepoints).
- K-means clusters identified a 'multiple sleep problems with daytime dysfunction' phenotype with the highest risk across outcomes.
- Mediation analyses indicated postoperative sleep disturbance and depression significantly mediated long-term adverse outcomes.
Methodological Strengths
- Large multicenter cohort with comprehensive perioperative outcome capture across acute and long-term timepoints.
- Use of clustering to define sleep phenotypes and mediation analysis to probe mechanistic pathways.
Limitations
- Observational design with potential residual confounding; sleep quality assessed by self-report (PSQI).
- Age range limited to 40–65 years; generalizability to older or younger populations is uncertain.
Future Directions: Randomized trials testing perioperative sleep optimization and mental health interventions in high-risk phenotypes; integration of objective sleep measures (actigraphy/polysomnography) and biological markers.
BACKGROUND: Despite of the established association between sleep disturbance and impaired health, these association among the Chinese surgical patients are lacking. METHOD: This study utilized data from the China Surgery and Anesthesia Cohort (CSAC) which included patients aged 40-65 years who underwent surgery at four medical centers between July 15, 2020 and November 24, 2023. Preoperative sleep quality one month before surgery was assessed using Pittsburgh Sleep Quality Index(PSQI), and sleep patterns were identified through k-means clustering. We ascertained two intraoperative, nine within-hospital, and eight after-discharge adverse outcomes. Logistic regression models were used to examine the interested associations. We additionally used mediation analyses to evaluate the mediating role of postoperative neuropsychological traits on the studied associations. RESULTS: The mean age of 14,129 included participants was 52.3 years with a predominance of females (58.8 %). Preoperative sleep disturbance was associated with two within-hospital (odds ratios[ORs] = 1.19-1.52) and all eight after-discharge adverse outcomes, with the most pronounced ORs observed for postoperative moderate-to-severe sleep disturbance(ORs = 3.88-18.64 at 1 month, 3.44-13.31 at 6 months, and 3.98-15.58 at 12 months), and depression(1.88-3.30 at 1 month, 2.20-3.96 at 6 months, and 2.44-5.60 at 12 months), compared with no sleep disturbance group. Analyses of preoperative sleep patterns indicated that compared to the 'least affected' group, patients featured by the 'multiple sleep problems with daytime dysfunction' obtained the highest estimates for the majority of studied adversities. Mediation analyses identified moderate-to-severe sleep disturbance and depression after surgery were significant mediators of longer-term adverse outcomes. CONCLUSIONS: Preoperative sleep disturbance was significantly associated with multiple adverse outcomes. These findings underscore the importance of assessing and managing sleep quality to improve overall prognosis.